BSE filing, NSE: SYRMA. Summary written from the filing by ALFA Finder's alert engine.
Syrma SGS Technology Ltd: key numbers
- Share price
- ₹1,563.00
- Market cap
- ₹30,082 Cr
- Revenue (annual)
- ₹4,819 Cr
- Net profit (annual)
- ₹317.8 Cr
- P/E (TTM)
- 81.7×Sector 42.1×
- Promoter holding
- 41.63%-0.65% QoQ
- FII holding
- 9.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syrma SGS Technology Ltd
All →Syrma SGS Technology Earnings Call Transcript: Key Takeaways
Syrma delivered an exceptionally strong Q1 with 67% revenue growth and 112% PAT growth, driven by export buoyancy and ODM traction.
- Call
- Guides 35% growth
Syrma SGS Technology Board Meeting Date
Syrma SGS Technology has scheduled a board meeting for October 30, 2026, to consider and approve the company's standalone and consolidated financial results.
Syrma SGS Technology Other Announcement
Syrma SGS Technology Limited has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per Regulation 31 of SEBI LODR.
Syrma SGS Technology Capital Structure Change
Franklin Templeton Mutual Fund sold 110,190 equity shares of Syrma SGS Technology Ltd via open market. The transaction reduced its holding from 3.069% to 3.012%.
Syrma SGS Technology Capacity Expansion
Syrma Johari MedTech inaugurated a new Medical Plastics and Precision Molding Facility in Jodhpur. The 120,000+ sq. ft. plant expands the group's MedTech manufacturing capabilities.
- plant floor area
- 120000 sq. ft.
Syrma SGS Technology Management Change
Syrma SGS Technology Limited clarifies the appointment of Mr. Jayesh Nagindas Doshi as Whole-time Director, effective August 25, 2026.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr